Andrew Michael Intlekofer

Andrew Michael Intlekofer is an Assistant Professor of Medicine at Weill Cornell Medical College since 2017. His work bridges oncology, immunology, and metabolic research, focusing on hematologic malignancies and tumor-immune interactions.

• Education:
  • M.D., University of Pennsylvania School of Medicine (2009)
  • Ph.D., University of Pennsylvania (2007)
  • B.S., University of Maryland (2001)

His research explores metabolic reprogramming in cancer cells, epigenetic dysregulation in leukemia/lymphoma, and immunotherapy mechanisms, particularly involving T cell metabolism. He has contributed to clinical trials in lymphoma and Hodgkin lymphoma.

The 15 most recent publications (2025–2021) span oncology, immunology, and molecular biology, with recurring themes in B-cell lymphomas, T cell metabolic flexibility, epigenetic modifiers, and oncometabolites.

Key subfields include targeted therapy resistance, immune checkpoint inhibition, mitochondrial dysfunction in tumors, and genomic profiling for precision oncology. His work often integrates clinical data and preclinical models to address therapeutic challenges.